Search by Drug Name or NDC
NDC 00093-1921-06 Cyclobenzaprine Hydrochloride 30 mg/1 Details
Cyclobenzaprine Hydrochloride 30 mg/1
Cyclobenzaprine Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is CYCLOBENZAPRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.
Related Packages: 00093-1921-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Cyclobenzaprine
Product Information
| NDC | 00093-1921 |
|---|---|
| Product ID | 0093-1921_a7cfb9fd-4417-4319-85c6-92c6fcad4085 |
| Associated GPIs | 75100050107030 |
| GCN Sequence Number | 062178 |
| GCN Sequence Number Description | cyclobenzaprine HCl CAP ER 24H 30 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 97960 |
| HICL Sequence Number | 001950 |
| HICL Sequence Number Description | CYCLOBENZAPRINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Cyclobenzaprine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cyclobenzaprine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA021777 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-1921-06 (00093192106)
| NDC Package Code | 0093-1921-06 |
|---|---|
| Billing NDC | 00093192106 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06) |
| Marketing Start Date | 2019-03-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |